This video examines an exploratory analysis of the RESORCE trial, which tested regorafenib vs placebo in hepatocellular carcinoma patients following radiographic progression on sorafenib.
Richard S. Finn, MD
Advertisement
Articles by Richard S. Finn, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC
3
IMNN-001 Plus Neoadjuvant Chemo Improves OS in Advanced Ovarian Cancer
4
Nadofaragene Firadenovec Label Update Approved in BCG-Unresponsive NMIBC
5